MedImmune Inc. deal

MEDI (Gaithersburg, Md.) acquired worldwide exclusive rights to commercialize T10B9, an anti-T cell murine monoclonal antibody developed at the University of Kentucky.

In a 76-patient,

Read the full 252 word article

How to gain access

Continue reading with a
two-week free trial.